CorMedix (CRMD) Tops Q3 EPS by 83c
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Join SI Premium – FREE
CorMedix (NASDAQ: CRMD) reported Q3 EPS of $1.26, $0.83 better than the analyst estimate of $0.43. Revenue for the quarter came in at $104.28 million versus the consensus estimate of $65.92 million.
For earnings history and earnings-related data on CorMedix (CRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Clariant AG (CLN:SW) (CLZNY) PT Raised to CHF13 at JPMorgan
- Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
